Marjan Van Blerk

Influence of dabigatran and rivaroxaban on routine coagulation assays

Els Bailleul, Bernard Châtelain, Anne Demulder et al. · Thrombosis and Haemostasis · 2014 · 79 citations · Full text

Medicine, Hematology, Pharmacology +15

Guidelines for blood smear preparation and staining procedure for setting up an external quality assessment scheme for blood smear interpretation. Part I: control material

Juan-Lluis Vives Corrons, Stéphanie Albarède, G Flandrin et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2004 · 46 citations

Medicine, Hematology, Pathology +14

Analytical and Clinical Evaluation of Creatine Kinase MB Mass Assay by IMx: Comparison with MB Isoenzyme Activity and Serum Myoglobin for Early Diagnosis of Myocardial Infarction

Marjan Van Blerk, Véronique Maes, Luc Huyghens et al. · Clinical Chemistry · 1992 · 39 citations

Life Sciences, Biochemistry, Cardiology +13

From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.

Jan Damoiseaux, Nancy Agmon‐Levin, Marjan Van Blerk et al. · PubMed · 2014 · 38 citations

Life Sciences, Immunology, Internal Medicine +15

Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme

Marjan Van Blerk, Els Bailleul, Bernard Châtelain et al. · International Journal of Laboratory Hematology · 2017 · 27 citations · Full text

Medicine, Hematology, Pharmacology +17